European Medicines Agency advises on compassionate use of a new combination therapy for chronic hepatitis C

View source ↗

Summary

EMA advises on compassionate use of a new combination therapy for chronic hepatitis C, outlining recommendations for access and use in compassionate settings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C